Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OrCam Technologies is a global leader in AI-driven assistive technology, dedicated to empowering individuals who are blind, visually impaired, or have reading difficulties. Founded in 2010 by the visionaries behind Mobileye, the company utilizes sophisticated computer vision and machine learning to translate visual information into spoken word. Its flagship wearable device, OrCam MyEye, attaches to eyeglasses and can discreetly read text, recognize faces, and identify products in real-time. Additionally, the OrCam Read handheld device supports individuals with dyslexia and reading fatigue by capturing full pages of text instantly. OrCam's mission is to harness the power of artificial vision to provide greater independence and accessibility for millions of people worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OrCam.